VELO AND THE McLAREN FORMULA 1 TEAM’S FAN-DESIGNED LIVERY TAKES CENTRE STAGE AS LANDO NORRIS WINS 2025 DRIVERS’ CHAMPIONSHIP IN ABU DHABI
ABU DHABI, UAE, Dec. 8, 2025 /PRNewswire/ -- Yesterday, the McLaren Formula 1®…
Servier’s Voranigo (vorasidenib) Receives Prix Galien Awards Across Multiple Regions
Voranigo® has been awarded the Prix Galien USA, the Prix Galien Poland and…
DAR GLOBAL AND ART DISTRICT REAL ESTATE DEVELOPMENT ANNOUNCE ‘MAD’, MUSCAT’S MARINE, ART & DIGITAL DISTRICT
MUSCAT, Oman, Dec. 8, 2025 /PRNewswire/ -- Dar Global (LSE: DAR), the…
Numeros Motors Ditches Surveys for ‘Voicebox’, Capturing Unfiltered Customer Insights for n-First Launch
BENGALURU, India, Dec. 8, 2025 /PRNewswire/ -- Voicebox (vbx.ai), the enterprise platform…
Riyadh Air and IBM Partner to Launch World’s First AI-Native Airline
Riyadh Air's AI‑powered operations create agility across the business and unify employee…
Cycle Pure Agarbathi Supports the 2nd Edition of Ability Sports League (ASL) T20
Cycle Pure Agarbathi, India’s leading agarbathi manufacturer, continues its commitment to inclusive…
More Indians Getting Access to Credit as ML Improves Lending Decisions: Experian Report
93% of lenders using Machine Learning (ML) for vehicle loans report higher…
Bybit and Circle Forge Strategic Partnership to Advance Global USDC Adoption
DUBAI, UAE, Dec. 8, 2025 /PRNewswire/ --Â Bybit, the world's second-largest cryptocurrency exchange…
Amphista Therapeutics presents new preclinical data showing the potential of its BRD9 Targeted Glue, AMX-883, to transform the treatment paradigm for acute myeloid leukaemia
Amphista Therapeutics presents new preclinical data showing the potential of its BRD9…
EpiEndo Pharmaceutical’s ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients
ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in…